rs143059463
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3
The NM_001130987.2(DYSF):c.5102C>T(p.Thr1701Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,614,188 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1701R) has been classified as Pathogenic.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.5102C>T | p.Thr1701Met | missense_variant | 46/56 | ENST00000410020.8 | NP_001124459.1 | |
DYSF | NM_003494.4 | c.4985C>T | p.Thr1662Met | missense_variant | 45/55 | ENST00000258104.8 | NP_003485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.5102C>T | p.Thr1701Met | missense_variant | 46/56 | 1 | NM_001130987.2 | ENSP00000386881.3 | ||
DYSF | ENST00000258104.8 | c.4985C>T | p.Thr1662Met | missense_variant | 45/55 | 1 | NM_003494.4 | ENSP00000258104.3 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152184Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251490Hom.: 1 AF XY: 0.0000883 AC XY: 12AN XY: 135922
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461886Hom.: 0 Cov.: 35 AF XY: 0.0000344 AC XY: 25AN XY: 727246
GnomAD4 genome AF: 0.000158 AC: 24AN: 152302Hom.: 1 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74460
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2B Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 27, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Nov 07, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 02, 2022 | Variant summary: DYSF c.4985C>T (p.Thr1662Met) results in a non-conservative amino acid change located in one of the C2 repeat domains (IPR000008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 282882 control chromosomes in the gnomAD database, including 1 homozygote. This frequency is not higher than the estimated maximum expected for a pathogenic variant in DYSF causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (0.0031), allowing no conclusion about variant significance. c.4985C>T has been reported in the literature in compound heterozygous state (with a VUS in trans) in an individual with suspected Limb-Girdle Muscular Dystrophy (Yu_2017, Zhong_2021), and in heterozygous state in an individual with myalgia (Bevilacqua_2020 through LOVD). These reports do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 02, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 26, 2019 | - - |
Qualitative or quantitative defects of dysferlin Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at